Pharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Details for Patent: 6,794,370

« Back to Dashboard

Which drugs does patent 6,794,370 protect, and when does it expire?

Patent 6,794,370 protects CAMPTOSAR and is included in one NDA. There has been one Paragraph IV challenge on Camptosar.

Protection for CAMPTOSAR has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

Summary for Patent: 6,794,370

Title: Method for treating cancer using camptothecin derivatives and 5-fluorouracil
Abstract:A combination therapy for treating cancer including administering at least one camptothecin derivative in conjunction with another anticancer agent. The combination therapy is preferably used as a first-line therapy for treating metastatic colorectal cancer and preferably involves administration of a combination of CPT-11, 5-fluorouracil and folinic acid, according to specific infusional treatment schedules which show therapeutic synergy in the treatment of cancer.
Inventor(s): Achterrath; Wolf R. (Dectzenbach, DE)
Assignee: Aventis Pharma S.A. (Antony Cedex, FR)
Application Number:10/124,458
Patent Claim Types:
see list of patent claims
Use; Delivery;

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Pfizer Inc
irinotecan hydrochloride
INJECTABLE;INJECTION020571-001Jun 14, 1996RXYesYes6,794,370*PED► SubscribeY
Pfizer Inc
irinotecan hydrochloride
INJECTABLE;INJECTION020571-002Jun 14, 1996RXYesYes6,794,370*PED► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.